Remdesivir and COVID-19 - Authors' reply.
作者信息
Wang Yeming, Gu Xiaoying, Xu Jiuyang, Cao Bin, Wang Chen
机构信息
Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China.
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
出版信息
Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8.
Abstract
摘要
相似文献
1
Remdesivir and COVID-19 - Authors' reply.瑞德西韦与2019冠状病毒病——作者回复
Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8.
2
Compassionate Use of Remdesivir in Covid-19. Reply.瑞德西韦在新冠病毒病中的同情用药。回复。
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
3
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
4
Remdesivir and COVID-19.瑞德西韦与新型冠状病毒肺炎
Lancet. 2020 Oct 3;396(10256):952. doi: 10.1016/S0140-6736(20)32021-3.
5
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠病毒病中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
6
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
7
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
8
Compassionate Use of Remdesivir in Covid-19.瑞德西韦在新冠疫情中的同情用药
N Engl J Med. 2020 Jun 18;382(25):e101. doi: 10.1056/NEJMc2015312. Epub 2020 May 15.
9
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权：透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
10
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
引用本文的文献
1
Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios.COVID-19的诊断、疫苗、治疗及发病机制与临床案例分析
Clin Pract. 2021 May 19;11(2):309-321. doi: 10.3390/clinpract11020044.
本文引用的文献
1
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.疫情危机期间瑞德西韦治疗新型冠状病毒肺炎患者的中国临床试验数据监测
Ther Innov Regul Sci. 2020 Sep;54(5):1236-1255. doi: 10.1007/s43441-020-00159-7. Epub 2020 May 16.
2
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.瑞德西韦对比标准治疗对 11 天内中症 COVID-19 患者临床状态的影响：一项随机临床试验。
JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349.
3
Efficacy of Remdesivir in COVID-19.瑞德西韦治疗新型冠状病毒肺炎的疗效
JAMA. 2020 Sep 15;324(11):1041-1042. doi: 10.1001/jama.2020.16337.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.评估静脉用瑞德西韦治疗成人重症 COVID-19 的疗效和安全性：一项 3 期随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.
6
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
7
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.预防性和治疗性瑞德西韦（GS-5734）治疗中东呼吸综合征冠状病毒感染恒河猴模型。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.
8
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.广谱抗病毒药物GS-5734可抑制流行性冠状病毒和人畜共患冠状病毒。
Sci Transl Med. 2017 Jun 28;9(396). doi: 10.1126/scitranslmed.aal3653.
Zotero 插件